{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Nikethamide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Nikethamide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Nikethamide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "nikethamide",
    "trial_2_text": "Nikethamide  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Nikethamide Supplement: 60 participants will take Nikethamide 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Nikethamide. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Nikethamide  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "78": 0.22343000769615173,
      "87": 0.2173444628715515,
      "177": 0.1701129674911499,
      "123": 0.15884166955947876,
      "37": 0.15803836286067963,
      "173": 0.14735817909240723,
      "21": 0.14189158380031586,
      "14": 0.13942326605319977,
      "17": 0.1376894861459732,
      "46": 0.13331949710845947,
      "20": 0.13230472803115845,
      "68": 0.12251798063516617,
      "2": 0.12128642946481705,
      "9": 0.11723632365465164,
      "79": 0.1116197258234024,
      "189": 0.11036961525678635,
      "67": 0.10829539597034454,
      "77": 0.10690651834011078,
      "200": 0.1068340390920639,
      "49": 0.10629787296056747,
      "114": 0.10398587584495544,
      "350": 0.1007818728685379,
      "228": 0.09976495802402496,
      "5": 0.09735368192195892,
      "188": 0.09574255347251892,
      "64": 0.07891969382762909,
      "72": 0.07837239652872086,
      "85": 0.07683061063289642,
      "193": 0.07666579633951187,
      "126": 0.07587930560112,
      "27": 0.07560375332832336,
      "76": 0.07500533759593964,
      "104": 0.07479081302881241,
      "28": 0.07423369586467743,
      "29": 0.0742068663239479,
      "239": 0.0729648545384407,
      "243": 0.07269523292779922,
      "101": 0.0724533349275589,
      "86": 0.07245224714279175,
      "276": 0.07220202684402466,
      "180": 0.0701722577214241,
      "61": 0.06574421375989914,
      "116": 0.06552086770534515,
      "139": 0.06502309441566467,
      "131": 0.06436703354120255,
      "30": 0.06385546177625656,
      "18": 0.06258078664541245,
      "179": 0.06123135983943939,
      "147": 0.060571134090423584,
      "69": 0.05920486897230148,
      "144": 0.05888308584690094,
      "396": 0.0586361400783062,
      "102": 0.05844781920313835,
      "194": 0.05707171559333801,
      "82": 0.056217584758996964,
      "151": 0.05593204125761986,
      "204": 0.05564031004905701,
      "92": 0.05383893474936485,
      "38": 0.05291168391704559,
      "253": 0.051960352808237076,
      "122": 0.05188906192779541,
      "269": 0.05173288285732269,
      "1": 0.051138993352651596,
      "282": 0.05092543363571167,
      "466": 0.0503486730158329,
      "164": 0.049748994410037994,
      "441": 0.04865771904587746,
      "97": 0.04808556288480759,
      "75": 0.04648445174098015,
      "261": 0.04591274634003639,
      "186": 0.04533637687563896,
      "33": 0.044501159340143204,
      "234": 0.0444488450884819,
      "355": 0.04440680146217346,
      "96": 0.043530192226171494,
      "400": 0.04321826249361038,
      "508": 0.04278247803449631,
      "262": 0.042566362768411636,
      "4": 0.04230708256363869,
      "153": 0.04207798093557358,
      "191": 0.04173346608877182,
      "288": 0.0417209267616272,
      "163": 0.04135118052363396,
      "35": 0.041328318417072296,
      "341": 0.041312120854854584,
      "98": 0.04095190018415451,
      "132": 0.03908111900091171,
      "454": 0.03895187750458717,
      "339": 0.03875233978033066,
      "382": 0.03858622908592224,
      "286": 0.03835095465183258,
      "268": 0.03780161216855049,
      "11": 0.037556443363428116,
      "456": 0.03743784502148628,
      "221": 0.0368952639400959,
      "249": 0.03678807243704796,
      "130": 0.0367303304374218,
      "494": 0.03665180131793022,
      "394": 0.036501578986644745,
      "100": 0.0362711101770401
    },
    "trial_2_ae": {
      "78": 0.22343000769615173,
      "87": 0.2173444628715515,
      "177": 0.1701129674911499,
      "123": 0.15884166955947876,
      "37": 0.15803836286067963,
      "173": 0.14735817909240723,
      "21": 0.14189158380031586,
      "14": 0.13942326605319977,
      "17": 0.1376894861459732,
      "46": 0.13331949710845947,
      "20": 0.13230472803115845,
      "68": 0.12251798063516617,
      "2": 0.12128642946481705,
      "9": 0.11723632365465164,
      "79": 0.1116197258234024,
      "189": 0.11036961525678635,
      "67": 0.10829539597034454,
      "77": 0.10690651834011078,
      "200": 0.1068340390920639,
      "49": 0.10629787296056747,
      "114": 0.10398587584495544,
      "350": 0.1007818728685379,
      "228": 0.09976495802402496,
      "5": 0.09735368192195892,
      "188": 0.09574255347251892,
      "64": 0.07891969382762909,
      "72": 0.07837239652872086,
      "85": 0.07683061063289642,
      "193": 0.07666579633951187,
      "126": 0.07587930560112,
      "27": 0.07560375332832336,
      "76": 0.07500533759593964,
      "104": 0.07479081302881241,
      "28": 0.07423369586467743,
      "29": 0.0742068663239479,
      "239": 0.0729648545384407,
      "243": 0.07269523292779922,
      "101": 0.0724533349275589,
      "86": 0.07245224714279175,
      "276": 0.07220202684402466,
      "180": 0.0701722577214241,
      "61": 0.06574421375989914,
      "116": 0.06552086770534515,
      "139": 0.06502309441566467,
      "131": 0.06436703354120255,
      "30": 0.06385546177625656,
      "18": 0.06258078664541245,
      "179": 0.06123135983943939,
      "147": 0.060571134090423584,
      "69": 0.05920486897230148,
      "144": 0.05888308584690094,
      "396": 0.0586361400783062,
      "102": 0.05844781920313835,
      "194": 0.05707171559333801,
      "82": 0.056217584758996964,
      "151": 0.05593204125761986,
      "204": 0.05564031004905701,
      "92": 0.05383893474936485,
      "38": 0.05291168391704559,
      "253": 0.051960352808237076,
      "122": 0.05188906192779541,
      "269": 0.05173288285732269,
      "1": 0.051138993352651596,
      "282": 0.05092543363571167,
      "466": 0.0503486730158329,
      "164": 0.049748994410037994,
      "441": 0.04865771904587746,
      "97": 0.04808556288480759,
      "75": 0.04648445174098015,
      "261": 0.04591274634003639,
      "186": 0.04533637687563896,
      "33": 0.044501159340143204,
      "234": 0.0444488450884819,
      "355": 0.04440680146217346,
      "96": 0.043530192226171494,
      "400": 0.04321826249361038,
      "508": 0.04278247803449631,
      "262": 0.042566362768411636,
      "4": 0.04230708256363869,
      "153": 0.04207798093557358,
      "191": 0.04173346608877182,
      "288": 0.0417209267616272,
      "163": 0.04135118052363396,
      "35": 0.041328318417072296,
      "341": 0.041312120854854584,
      "98": 0.04095190018415451,
      "132": 0.03908111900091171,
      "454": 0.03895187750458717,
      "339": 0.03875233978033066,
      "382": 0.03858622908592224,
      "286": 0.03835095465183258,
      "268": 0.03780161216855049,
      "11": 0.037556443363428116,
      "456": 0.03743784502148628,
      "221": 0.0368952639400959,
      "249": 0.03678807243704796,
      "130": 0.0367303304374218,
      "494": 0.03665180131793022,
      "394": 0.036501578986644745,
      "100": 0.0362711101770401
    }
  },
  "safety": {
    "trial_1_safety": 0.340583860874176,
    "trial_2_safety": 0.340583860874176
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4788677990436554
  }
}